参芪复方对KKAy小鼠糖尿病大血管病变骨骼肌差异基因表达影响的实验研究
|
摘要
目的：拟探寻参芪复方对糖尿病大血管病变中骨骼肌的保护作用,并揭示其作用机理,为临床用药提供理论依据。
方法：KKAy小鼠喂饲含有L-NAME饮水同时喂饲高脂饲料以复制2型糖尿病大血管病变模型。入选小鼠随机分为KKAy组、模型组、参芪复方组和罗格列酮组,每组15只。另设15只C57BL/6J小鼠为正常组,共5组。造模同时开始给药,连续8周,期间观察动物一般状况,摄食饮水情况,体重变化情况,监测血糖。实验结束后测量各组小鼠血脂、血清胰岛素,计算胰岛素抵抗指数,观察腹主动脉、骨骼肌的形态学改变,并应用基因芯片技术对参芪复方组-模型组、模型组-KKAy组的骨骼肌进行差异基因检测。
结果：参芪复方可改善模型动物的一般状态,减少多饮、多食的状况,减轻体重,降低血糖,降低血清TC、 TG水平(P<0.05)。参芪复方可减轻模型动物腹主动脉内膜水肿,减轻骨骼肌细胞萎缩、水肿、断裂和炎症状况。参芪复方组-模型组、模型组-KKAy组的差异表达基因均涉及多个生物学过程和多个信号通路,两个比较组差异基因均涉及的生物学过程为细胞死亡,均涉及的信号通路为代谢途径和细胞周期。两个比较组呈逆向表达的7条差异基因为Celsr2、 Rilp11、 Dlx6as、2010004M13Rik、Anapc13、 Gm6097、Ddx39b。
结论：参芪复方可改善模型动物的一般状态,减轻其多饮、多食、肥胖的状况,可降低血糖,调节糖、脂代谢紊乱状态。参芪复方可改善模型动物骨骼肌细胞萎缩、水肿、断裂和炎症状况,减轻骨骼肌细胞的损伤。参芪复方可对糖尿病大血管病变中骨骼肌起保护作用,其机理可能与调节细胞死亡途径、调节代谢和细胞周期通路以及调控Celsr2、Rilp11、 Dlx6as、2010004M13Rik、 Anapc13、 Gm6097、 Ddx39b基因表达有关。
Objective:To explore the protective effects and mechanisms of ShenQi compound recipe on the skeletal muscle of diabetic macrovascular complication, provide a theoretical basis for the clinical use of drugs.
Methods:The KKAy mice fed water containing Nco-nitro-L-arginine Methyl Ester (L-NAME) and high fat diet at the same time to copy the macrovascular complications of type2diabetes model. Selected KKAy mice were randomly divided into KKAy group, model group, ShenQi compound recipe group and rosiglitazone group (n=15), another15C57BL/6J mice as the normal group, a total of five groups. Modeling at the same time began to be fed drugs for8weeks. During the experiment periodes, observed the general status and measured the account of the water drinking, food intake and body weight, monitored blood glucose. After the end of the experiment, measured each group of mice blood lipids, serum insulin, calculated insulin resistance index, observed the morphological changes of the abdominal aorta and skeletal muscle, and used gene chip technology to detect differentially expressed genes of the ShenQi compound recipe and model group, model group and KKAy group.
Results:ShenQi compound recipe could improve the general state of the KKAy mice, reduce polydipsia, polyphagia, lose weight, lower blood sugar, reduce serum TC, TG level (P<0.05). ShenQi compound recipe could improve abdominal aortic intimal edema, improve the gastrocnemius muscle atrophy, edema, fracture, inflammatory state situation. Differentially expressed genes between ShenQi compound recipe group and model group were involved in many biological processes and pathways. Differentially expressed genes between model group and KKAy group were also involved in many biological processes and pathways. Two comparison groups differentially expressed genes were all involved in the biological process of cell death, were all involved in signaling pathways of metabolic pathways and cell cycle. In two comparison groups7genes (Celsr2, Rilpll, Dlx6as,2010004M13Rik, Anapc13, Gm6097, Ddx39b) expression in reverse were found.
Conclusion:ShenQi compound recipe had the role of improving the general state of the KKAy mice, reducing KKAy mice polydipsiapolyphagia, obesity status, lower the blood suglar and regulating the disorder of glucose and lipid. The ShenQi compound recipe had the role of improving skeletal muscle of DM macrovascular complication atrophy, edema, fracture, inflammatory state. The effects and mechanisms of ShenQi compound recipe on the skeletal muscle of diabetic macrovascular complication may be relationed to regulate cell death process, metabolic and cell cycle pathways and regulate the gene expression of Celsr2, Rilpll Dlx6as,2010004M13Rik, Anapc13, Gm6097and Ddx39b.
方法：KKAy小鼠喂饲含有L-NAME饮水同时喂饲高脂饲料以复制2型糖尿病大血管病变模型。入选小鼠随机分为KKAy组、模型组、参芪复方组和罗格列酮组,每组15只。另设15只C57BL/6J小鼠为正常组,共5组。造模同时开始给药,连续8周,期间观察动物一般状况,摄食饮水情况,体重变化情况,监测血糖。实验结束后测量各组小鼠血脂、血清胰岛素,计算胰岛素抵抗指数,观察腹主动脉、骨骼肌的形态学改变,并应用基因芯片技术对参芪复方组-模型组、模型组-KKAy组的骨骼肌进行差异基因检测。
结果：参芪复方可改善模型动物的一般状态,减少多饮、多食的状况,减轻体重,降低血糖,降低血清TC、 TG水平(P<0.05)。参芪复方可减轻模型动物腹主动脉内膜水肿,减轻骨骼肌细胞萎缩、水肿、断裂和炎症状况。参芪复方组-模型组、模型组-KKAy组的差异表达基因均涉及多个生物学过程和多个信号通路,两个比较组差异基因均涉及的生物学过程为细胞死亡,均涉及的信号通路为代谢途径和细胞周期。两个比较组呈逆向表达的7条差异基因为Celsr2、 Rilp11、 Dlx6as、2010004M13Rik、Anapc13、 Gm6097、Ddx39b。
结论：参芪复方可改善模型动物的一般状态,减轻其多饮、多食、肥胖的状况,可降低血糖,调节糖、脂代谢紊乱状态。参芪复方可改善模型动物骨骼肌细胞萎缩、水肿、断裂和炎症状况,减轻骨骼肌细胞的损伤。参芪复方可对糖尿病大血管病变中骨骼肌起保护作用,其机理可能与调节细胞死亡途径、调节代谢和细胞周期通路以及调控Celsr2、Rilp11、 Dlx6as、2010004M13Rik、 Anapc13、 Gm6097、 Ddx39b基因表达有关。
Objective:To explore the protective effects and mechanisms of ShenQi compound recipe on the skeletal muscle of diabetic macrovascular complication, provide a theoretical basis for the clinical use of drugs.
Methods:The KKAy mice fed water containing Nco-nitro-L-arginine Methyl Ester (L-NAME) and high fat diet at the same time to copy the macrovascular complications of type2diabetes model. Selected KKAy mice were randomly divided into KKAy group, model group, ShenQi compound recipe group and rosiglitazone group (n=15), another15C57BL/6J mice as the normal group, a total of five groups. Modeling at the same time began to be fed drugs for8weeks. During the experiment periodes, observed the general status and measured the account of the water drinking, food intake and body weight, monitored blood glucose. After the end of the experiment, measured each group of mice blood lipids, serum insulin, calculated insulin resistance index, observed the morphological changes of the abdominal aorta and skeletal muscle, and used gene chip technology to detect differentially expressed genes of the ShenQi compound recipe and model group, model group and KKAy group.
Results:ShenQi compound recipe could improve the general state of the KKAy mice, reduce polydipsia, polyphagia, lose weight, lower blood sugar, reduce serum TC, TG level (P<0.05). ShenQi compound recipe could improve abdominal aortic intimal edema, improve the gastrocnemius muscle atrophy, edema, fracture, inflammatory state situation. Differentially expressed genes between ShenQi compound recipe group and model group were involved in many biological processes and pathways. Differentially expressed genes between model group and KKAy group were also involved in many biological processes and pathways. Two comparison groups differentially expressed genes were all involved in the biological process of cell death, were all involved in signaling pathways of metabolic pathways and cell cycle. In two comparison groups7genes (Celsr2, Rilpll, Dlx6as,2010004M13Rik, Anapc13, Gm6097, Ddx39b) expression in reverse were found.
Conclusion:ShenQi compound recipe had the role of improving the general state of the KKAy mice, reducing KKAy mice polydipsiapolyphagia, obesity status, lower the blood suglar and regulating the disorder of glucose and lipid. The ShenQi compound recipe had the role of improving skeletal muscle of DM macrovascular complication atrophy, edema, fracture, inflammatory state. The effects and mechanisms of ShenQi compound recipe on the skeletal muscle of diabetic macrovascular complication may be relationed to regulate cell death process, metabolic and cell cycle pathways and regulate the gene expression of Celsr2, Rilpll Dlx6as,2010004M13Rik, Anapc13, Gm6097and Ddx39b.
引文
[1]Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med:2010,362(12):1090-1101.
[2]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志,2012,20(1)：S3.
[3]Stuart C A, Wen G, Williamson M E, et al. Altered GLUT1 and GLUTS gene expression and subcellular redistribution of GLUT4:protein in muscle from patients with acanthosis nigricans and severe insulin resistance[J].Metabolism,2001,50(7):771-777.
[4]Wray C J, Sun X, Gang G I, et al. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle[J]. J Surg Res,2002,104(2):82-87.
[5]项静燕,赵玉武.糖尿病性骨骼肌病变发病机制的研究进展[J].中国老年学杂志,2009(22)：2976-2979.
[6]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠白色脂肪组织脂联素基因表达的影响[J].中成药,2006,28(7)：996-1001.
[7]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3)：249-253.
[8]谢毅强,谢春光,张红敏.参芪复方对GK大鼠2型糖尿病大血管病变CD36 mRNA及ox-LDL的影响[J].时珍国医国药,2007,18(8)：1812-1814.
[9]张红敏,谢春光,陈世伟,等.参芪复方对糖尿病早期大血管病变大鼠白色脂肪过氧化物酶体增生物激活受体γ的影响[J].中医杂志,2007,48(6)：549-551.
[10]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠PI3-K/Akt信号通路的影响[J].中医杂志,2011,52(1)：49-53.
[11]温俊平,林丽香,陈刚,等.2型糖尿病大鼠骨骼肌基因表达谱研究[J].中华内分泌代谢杂志,2006,22(5)：491-492.
[12]张曙云,沈征,钱凯先.2型糖尿病大鼠基因表达变化的研究[J].科技通报,2007,23(3)：368-371.
[13]李翔,刘志民,石勇铨,等.基因芯片技术筛选2型糖尿病伴远端对称性多神经病变患者外周血单个核细胞差异表达基因[J].第二军医大学学报,2006,27(10)：1072-1075.
[14]Haffher S M, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study[J]. Diabetes Care,1996,19(10):1138-1141.
[15]韩为东赵亚力马学斌.分子生物学基本实验技术[M].北京：清华大学出版社,2006.
[16]邓西方.参芪复方改善自发性糖尿病大鼠胰岛素抵抗及抗炎机理研究[D].成都中医药大学,2007.
[17]葛爱利.参芪复方对糖尿病血管病变患者血清脂联素、瘦素、抵抗素影响的临床研究[D].成都中医药大学,2011.
[18]李辉,朱天民,张卫华,等.参芪复方对2型糖尿病GK大鼠胰岛β细胞凋亡及Caspase-3表达的影响[J].中国老年学杂志,2008,28(24)：2412-2413.
[19]刘桠,谢春光,庄灿,等.参芪复方对GK大鼠2型糖尿病大血管病变内皮保护作用的实验研究[J].辽宁中医杂志,2010,37(6)：1163-1165.
[20]张琨,谢春光.参芪复方对GK大鼠2型糖尿病大血管病变氧化应激的影响[J].中华中医药杂志,2012,27(4)：]084-1087.
[21]陈敏,庄灿,谢春光,等.参芪复方对GK大鼠大血管病变内皮细胞凋亡影响的实验研究[J].时珍国医国药,2010,21(9)：2165-2166.
[22]孙凤平,钞建峰,郑君,等.参芪复方对GK大鼠肾PPAR y表达的影响[J].西部中医药,2011,21(11)：12-14.
[23]康健,刘桠,谢春光,等.参芪复方对GK大鼠心肌细胞凋亡相关因Bcl-2、 Bax及NO的影响[J].天津中医药,2009,26(6)：489-492.
[24]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3)：249-252.
[25]李辉,谢春光,朱天民.参芪复方对GK大鼠胰岛β细胞凋亡和诱导型一氧化氮合酶表达的影响[J].时珍国医国药,2008,19(1)：166-167.
[26]谢毅强,谢春光,张红敏.参芪复方对GK大鼠早期动脉硬化胰岛素抵抗的影响[J].海南医学院学报,2007,13(3)：204-207.
[27]王芬,何华亮,张红敏,等.参芪复方对GK大鼠脂代谢异常的实验研究[J].天津中医药,2007,24(6)：507-508.
[28]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠PI3-K/Akt信号通路的影响[J].中医杂志,2011,52(1)：49-52.
[29]张延群,韩清,和贵章,等.2080例糖尿病患者证候与血糖关系分析[J].中医杂志,1996,37(10)：6]7-619.
[30]张延群,韩清,和贵章,等.2080例糖尿病患者证候与血糖关系分析[J].中医杂志,1996,37(10)：617-619.
[31]杨维益,梁嵘,文平,等.脾气虚证大鼠骨骼肌的形态学和形态计量研究[J].中国运动医学杂志,1993(3)：157-159.
[32]Eriksson K F, Saltin B, Lindgarde F. Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance. A 15-year follow-up[J]. Diabetes,1994,43(6):805-808.
[33]蒙碧辉,黄彦云,冼苏,等.21例糖尿病患者骨骼肌毛细血管基底膜厚度分析[J].中华内分泌代谢杂志,1995,11(4)：244.
[34]项静燕,赵玉武.糖尿病性骨骼肌病变发病机制的研究进展[J].中国老年学杂志,2009(22)：2976-2979.
[35]Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature,2001,414(6865):813-820.
[36]Zisman A, Peroni O D, Abel E D, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance[J]. Nat Med,2000,6(8):924-928.
[37]Inoue M, Chang L, Hwang J, et al. The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin[J]. Nature,2003,422(6932):629-633.
[38]刘霞,金其贯,罗强.有氧运动和膳食控制对2型糖尿病大鼠骨骼肌InsR-PI3K-GLUT4信号通路的影响[J].中国运动医学杂志,2012(11)：988-993.
[39]张红学.运动提高糖尿病大鼠骨骼肌GLUT4基因表达的信号机制[J].体育学刊,2013,2(20)：2-6.
[40]Brand M D, Pamplona R, Portero-Otin M, et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3[J]. Biochem J,2002,368(Pt 2):597-603.
[41]Mcgee S L, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression:molecular mechanisms[J]. Clin Exp Pharmacol Physiol,2006,33(4):395-399.
[42]吴慧娟,张志刚.泛素-蛋白酶体途径及意义[J].国际病理科学与临床杂志,2006(1)：7-10.
[43]Takeshita M, Ina K, Kitamura H, et al. Ultrastructural study of capillary and myocytic changes in the masseter and heart of KK-Ay mice[J]. J Electron Microsc (Tokyo),1997,46(5):413-423.
[44]马春明,张宏.糖尿病骨骼肌病变发病机制[J].辽宁实用糖尿病杂志,2004,12(4)：51-53.
[45]Nakahash I T F J I R. V ascu lar endothelial cells syn thesize and secrete brain-derived neu rotroph ic factor[J]. FEBS Lett,2000,2(470):113-117.
[46]Gomez-Pinilla F. Ying Z. Opazo P. et al. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle[J]. Eur J Neurosci.2001.13(6):1078-1084.
[47]Shinoda M, Hoffer B J. Olson L. Interactions of neurotrophic factors GDNF and NT-3, but not BDNF, with the immune system following fetal spinal cord transplantation[J]. Brain Res,1996,722(1-2):153-167.
[48]Durham H A, Truett G E. Development of insulin resistance and hyperphagia in Zucker fatty rats[J]. Am J Physiol Regul Integr Comp Physiol,2006,290(3):R652-R658.
[49]Nakano D, Diah S, Kitada K, et al. Short-Term Calorie Restriction in Early Life Attenuates the Development of Proteinuria but Not Glucose Intolerance in Type 2 Diabetic OLETF Rats[J].1SRN Endocrinol,2011,2011:768637.
[50]尤杰,孙兆林,季宇彬,等.糖尿病动物模型的种类与研究进展[J].中国药业,2012(9)：1-4.
[51]Huang Y, Border W A, Yu L, et al. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathyfj]. J Am SocNephrol,2008,19(2):329-338.
[52]邹丰,欧阳静萍,毛先晴.黄芪多糖对遗传性糖尿病小鼠肝糖原含量的影响[J].微循环学杂志,2007(1)：12-14.
[53]郭清华,陆菊明,潘长玉.饮食能量对KKAy及Kk小鼠2型糖尿病发病的影响[J].军医进修学院学报,2005(2)：140-142.
[54]Kaie Ojamaa S Y H Y. Insulin resistance associated with decreased levels of insulin-receptor mRNA[J]. ournal of clinical endocrinology and metabolism.1998:1214-1220.
[55]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠PI3-K/Akt信号通路的影响[J].中医杂志,2011,52(1)：49-52.
[56]Kataoka C, Egashira K, Ishibashi M, et al. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis[J]. Am J Physiol Heart Circ Physiol,2004,286(2):H768-H774.
[57]Zhao Q, Egashira K, Inoue S, et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis[J]. Circulation,2002,105(9):l 110-1115.
[58]郑瑾,叶平.血管病变早期检测及临床意义[J].心血管康复医学杂志,2012(2)：207-210.
[59]李桂源.病理生理学[M].北京：人民卫生出版社,2010.
[60]沈杰,符鸿俊.罗格列酮对初发2型糖尿病患者血糖、胰岛β细胞功能和炎症因子的影响[J].中国现代医生,2012(32).
[61]邓向群,毕会民.罗格列酮对胰岛素抵抗大鼠骨骼肌蛋白激酶B表达的影响[J].中国新药与临床杂志,2004(5).
[62]胡君平.罗格列酮对2型糖尿病小鼠肌肉萎缩拮抗机制[D].郑州大学,2010.
[63]诸福棠胡亚美江载芳.实用儿科学[M].第7版.北京：人民卫生出版社,2005.
[64]马晖,谢春光.参芪复方降血糖实验研究[J].四川省卫生管理干部学院学报,2006,25(2)：87-89.
[65]Lee J H, Chan J L, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration:cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects[J]. J Clin Endocrinol Metab,2003,88(10):4848-4856.
[66]高泓.参芪复方调控糖尿病血管PB-K/Akt通路的实验研究[D].成都中医药大学,2009.
[67]王芬,何华亮,张红敏,等.参芪复方对GK大鼠脂代谢异常的实验研究[J].天津中医药,2007(6).
[68]姜荷艳,王锐.罗格列酮对2型糖尿病患者血脂及胰岛素抵抗的影响[J].中国误诊学杂志,2007,7(21)：5014-5015.
[69]Stuart C A, Wen G, Williamson M E, et al. Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4:protein in muscle from patients with acanthosis nigricans and severe insulin resistance[J]. Metabolism.2001,50(7):771-777.
[70]Wray C J, Sun X, Gang G I, et al. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle[J]. J Surg Res,2002,104(2):82-87.
[71]张宏,白景文,于德民,等.糖尿病性肌病的超微病理结构及可能机理[J].中国糖尿病杂志,2002,10(6)：326-329.
[72]张晓菲,杨景,张忠辉.罗格列酮对糖尿病大鼠骨骼肌损害防护作用的机制研究[J].中国医药指南,2012(24).
[73]Wang Z, Du Q, Wang F, et al. Microarray analysis of gene expression on herbal glycoside recipes improving deficient ability of spatial learning memory in ischemic mice[J]. J Neurochem,2004,88(6):1406-1415.
[74]周红光,陈海彬,王瑞平,等.代谢组学在中药复方研究中的应用[J].中国药理学通报,2013,29(2)：161-165.
[75]陈芝喜,徐志伟,刘小斌,等.脾虚证小鼠脾肾组织核酸和蛋白质含量变化及强肌健力口服液的影响(英文)[J].中国组织工程研究与临床康复,2007,11(8)：1581-1584.
[76]Cao P R, Kim H J, Lecker S H. Ubiquitin-protein ligases in muscle wasting[J]. Int J Biochem Cell Biol,2005,37(10):2088-2097.
[77]Yanagawa Y, Komatsu S. Ubiquitin/proteasome-mediated proteolysis is involved in the response to flooding stress in soybean roots, independent of oxygen Iimitation[J]. Plant Sci,2012,185-186:250-258.
[78]Larsen C N, Finley D. Protein translocation channels in the proteasome and other proteases[J]. Cell,1997,91 (4):431-434.
[79]Wu C, Zhang Y, Sun Z, et al. Molecular evolution of Cide family proteins:novel domain formation in early vertebrates and the subsequent divergence[J]. BMC Evol Biol,2008,8:159.
[80]Dupont-Versteegden E E. Apoptosis in skeletal muscle and its relevance to atrophy[J]. World J Gastroenterol,2006,12(46):7463-7466.
[81]Joza N, Pospisilik J A, Hangen E, et al. AIF:not just an apoptosis-inducing factor[J]. Ann N Y Acad Sci,2009,1171:2-11.
[82]Jin R, De Smaele E, Zazzeroni F, et al. Regulation of the gadd45beta promoter by NF-kappaB[J]. DNA Cell Biol,2002,21(7):491-503.
[83]Papa S, Zazzeroni F, Bubici C, et al. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2[J]. Nat Cell Biol,2004,6(2):146-153.
[84]Papa S, Zazzeroni F, Bubici C, et al. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2[J]. Nat Cell Biol,2004,6(2):146-153.
[85]Lang F, Henke G, Embark H M, et al. Regulation of channels by the serum and glucocorticoid-inducible kinase-implications for transport, excitability and cell proliferation[J]. Cell Physiol Biochem,2003,13(1):41-50.
[86]Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition[J]. Expert Opin Investig Drugs,2013.
[87]Pati D, Zhang N, Plon S E. Linking sister chromatid cohesion and apoptosis:role of Rad21[J]. Mol Cell Biol,2002,22(23):8267-8277.
[88]Meirelles G V, Silva J C, Mendonca Y A, et al. Human Nek6 is a monomeric mostly globular kinase with an unfolded short N-terminal domain[J]. BMC Struct Biol,2011,11(12):576-582.
[89]Dosztanyi Z, Csizmok V, Tompa P, et al. IUPred:web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content[J]. Bioinformatics,2005,21(16):3433-3434.
[90]Cheng J, Randall A Z, Sweredoski M J, et al. SCRATCH:a protein structure and structural feature prediction server[J]. Nucleic Acids Res,2005,33(Web Server issue):W72-W76.
[91]王萍.高学文.李润今.等.星形胶质细胞和神经元凋亡的细胞周期时相分布特征[J].中华神经医学杂志.2008.7(4)：329-332.
[92]唐振宇.大鼠脊髓损伤后NEK6表达的实验研究[J].淮海医药.2011.29(6)：473-475.
[93]Sasaki S, Nakamura T, Arakawa H, et al. Isolation and characterization of a novel gene, hRFI. preferentially expressed in esophageal cancer[J]. Oncogene,2002,21(32):5024-5030.
[94]张玉秀,柴团耀,赵文明.遍在蛋白系统[J].生命的化学,1999(5)：34-36.
[95]陈洪菊,屈艺,母得志.nTOR言号通路的生物学功能[J].生命的化学.2010,30(4)：555-561.
[96]马振莲,刘少君.轴突导向信号的研究进展[J].军事医学科学院院刊,2006,30(2)：180-183.
[97]Hadjantonakis A K, Sheward W J, Harmar A J, et al. Celsr1, a neural-specific gene encoding an unusual seven-pass transmembrane receptor, maps to mouse chromosome 15 and human chromosome 22qter[J]. Genomics,1997,45(1):97-104.
[98]Rocak S, Linder P. DEAD-box proteins:the driving forces behind RNA metabolism[J]. Nat Rev Mol Cell Biol,2004,5(3):232-241.
[99]Peelman L J, Chardon P, Nunes M, et al. The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family[J]. Genomics,1995,26(2):210-218.
[100]Sahni A, Wang N, Alexis J D. UAP56 is an important regulator of protein synthesis and growth in cardiomyocytes[J]. Biochem Biophys Res Commun,2010,393(1):106-110.
[101]Sahni A, Wang N, Alexis J D. UAP56 is a novel interacting partner of Bcr in regulating-vascular smooth muscle cell DNA synthesis[J]. Biochem Biophys Res Commun,2012,420(3):511-515.
[102]Deshaies R J, Joazeiro C A. RING domain E3 ubiquitin ligases[J]. Annu Rev Biochem,2009,78:399-434.
[103]Peters J M. Subunits and substrates of the anaphase-promoting complex[J]. Exp Cell Res,1999,248(2):339-349.
[104]Vogel G. Nobel Prizes. Gold medal from cellular trash[J]. Science,2004,306(5695):400-401.
[105]van Roessel P, Elliott D A, Robinson I M, et al. Independent regulation of synaptic size and activity by the anaphase-promoting complex[J]. Cell,2004,119(5):707-718.
[106]Weedon M N, Lango H, Lindgren C M, et al. Genome-wide association analysis identifies 20 loci that influence adult height[J]. Nat Genet,2008,40(5):575-583.
[1]马晖,谢春光.参芪复方降血糖实验研究[J].四川省卫生管理干部学院学报.2006,25(2)：87-89.
[2]王芬,何华亮,张红敏,等.参芪复方对GK大鼠脂代谢异常的实验研究[J].天津中医药,2007,24(6)：507-508.
[3]谢毅强,谢春光,张红敏.参芪复方对GK大鼠早期动脉硬化胰岛素抵抗的影响[J].海南医学院学报,2007,13(3)：204-207.
[4]邓西方.参芪复方改善自发性糖尿病大鼠胰岛素抵抗及抗炎机理研究[D].成都中医药大学,2007.
[5]李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4)：5-7.
[6]Freeman D J, Norrie J, Caslake M J, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study [J]. Diabetes,2002,51(5):1596-1600.
[7]Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue[J]. Circulation,2003,107(5):671-674.
[8]张红敏,陈世伟,谢春光,等.参芪复方抗自发性糖尿病GK大鼠早期动脉粥样硬化的作用机制[J].中国中药杂志,2006,31(15)：1272-1275.
[9]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3)：249-252.
[10]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠白色脂肪组织脂联素基因表达的影响[J].中成药,2006,27(7)：996-1000.
[11]禹远远,王瑞英,郝咏梅.血管内皮功能紊乱与糖尿病大血管病变[J].临床荟萃,2008,23(20)：1515-1517.
[12]段薇,张锦,张学梅,等.内皮抑素和血管内皮生长因子与2型糖尿病大血管病变的关系[J].中国动脉硬化杂志,2006,14(9)：799-801.
[13]巩秋红,刘晓民,于友涛.血清一氧化氮水平与2型糖尿病血管病变的关系[J].中国糖尿病杂志,2000,8(2)：103.
[14]Dhaliwal B S, Steinbrecher U P. Scavenger receptors and oxidized low density lipoproteins[J]. Clin Chim Acta,1999,286(1-2):191-205.
[15]Nakata A, Nakagawa Y, Nishida M, et al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta[J]. Arterioscler Thromb Vase Biol,1999,19(5):1333-1339.
[16]刘桠,谢春光,庄灿,等.参芪复方对GK大鼠2型糖尿病大血管病变内皮保护作用的实验研究[J].辽宁中医杂志,2010,37(6)：1163-1165.
[17]谢毅强,谢春光,张红敏.参芪复方对自发性糖尿病大鼠血管内皮保护的作用机制[J].中华中医药杂志,2008,23(3)：253-255.
[18]谢毅强.参芪复方对GK大鼠2型糖尿病大血管病变血管内皮细胞保护的实验研究[J].2006.
[19]金惠铭,李先涛.血管新生的调控[J].中国微循环,2001,5(2)：85-88.
[20]Moreno P R, Purushothaman K R, Zias E, et al. Neovascularization in human atherosclerosis[J]. Curr Mol Med,2006,6(5):457-477.
[21]Dai J, Rabie A B. VEGF:an essential mediator of both angiogenesis and endochondral ossification[J]. J Dent Res,2007,86(10):937-950.
[22]Adya R, Tan B K, Punn A, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis[J]. Cardiovasc Res,2008,78(2):356-365.
[23]刘桠.参芪复方调控GK大鼠血管PTEN/PI3K通路与血管新生的实验研究[J].2011.
[24]高泓.参芪复方调控糖尿病血管PI3-K/Akt通路的实验研究[J].2010.
[25]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠P13-K/Akt言号通路的影响[J].中医杂志,2011,52(1)：49-52.
[26]Nathan C, Xie Q W. Regulation of biosynthesis of nitric oxide[J]. J Biol Chem,1994,269(19):13725-13728.
[27]Fehsel K, Kroncke K D, Meyer K L, et al. Nitric oxide induces apoptosis in mouse thymocytes[J]. J Immunol,1995,155(6):2858-2865.
[28]Geng Y J, Hellstrand K, Wennmalm A, et al. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha[J]. Cancer Res,1996,56(4):866-874.
[29]李辉,朱天民,张卫华,等.参芪复方对2型糖尿病GK大鼠胰岛β细胞凋亡及Caspase-3表达的影响[J].中国老年学杂志,2008,28(24)：2412-2413.
[30]李辉,谢春光,朱天民.参芪复方对GK大鼠胰岛β细胞凋亡和诱导型一氧化氮合酶表达的影响[J].时珍国医国药,2008,19(1)：166-167.
[31]陈敏,庄灿,谢春光,等.参芪复方对GK大鼠大血管病变内皮细胞凋亡影响的实验研究[J].时珍国医国药,2010,21(9)：2165-2166.
[32]Talior I, Tennenbaum T, Kuroki T, et al. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice:role for NADPH oxidase[J]. Am J Physiol Endocrinol Metab,2005,288(2):405-411.
[33]张琨,谢春光.参芪复方对GK大鼠2型糖尿病大血管病变氧化应激的影响[J].中华中医药杂志,2012,27(4)：1084-1087.
[34]宋新磊,王静,崔焕先,等PPARy对脂类代谢和脂肪细胞分化的调控[J].云南农业大学学报,2008,23(6)：851-855.
[35]Nencioni A, Wesselborg S, Brossart P. Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses[J]. Crit Rev Immunol,2003,23(1-2):1-13.
[36]Soller M, Tautenhahn A, Brune B, et al. Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis[J]. J Leukoc Biol,2006,79(1):235-243.
[37]Artwohl M, Holzenbein T, Furnsinn C, et al. Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells[J]. Thromb Haemost,2005,93(5):810-815.
[38]Barzilay J I, Abraham L, Heckbert S R, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J]. Diabetes,2001,50(10):2384-2389.
[39]孙凤平,钞建峰,郑君,等.参芪复方对GK大鼠肾PPARγ表达的影响[J].西部中医药,2011,21(11)：12-14.
[40]曾娜.参芪复方对自发性糖尿病肾病大鼠血清CRP、TNF-α和E-selectin水平表达影响的研究[J].2011.
[41]张芳林.糖尿病性心肌病发病机理的研究进展[J].国外医学.内分泌学分册,2002,7(4)：245-247.
[42]温晨东,李兴.细胞因子与糖尿病心肌病变[J].医学综述,2006,12(1)：34-36.
[43]Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue[J]. Circulation,2003,107(5):671-674.
[44]Bojestig M, Nystrom F H, Amqvist H J, et al. The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes[J]. J Renin Angiotensin Aldosterone Syst,2000,1(4):353-356.
[45]Cai L, Li W, Wang G, et al. Hyperglycemia-induced apoptosis in mouse myocardium:mitochondrial cytochrome C-mediated caspase-3 activation pathway[J]. Diabetes,2002,51(6):1938-1948.
[46]De Falco M, Laforgia V, Fedele V, et al. Vasoactive intestinal peptide stimulation modulates the expression of Bcl-2 family members in the adrenal gland of the lizard Podarcis sicula[J]. Histochem J,2001,33(11-12):639-645.
[47]康健.刘桠.谢春光,等.参芪复方对GK大鼠心肌细胞凋亡相关因子Bcl-2、Bax及NO的影响[J].天津中医药.2009,26(6)：489-492.
[48]殷丽平,谢春光,张红敏,等.参芪复方对自发性糖尿病GK大鼠心肌LTGF-β1表达的影响[J].福建中医药,2009,40(3)：38-40.
[49]刘桠.参芪复方调控GK大鼠血管PTEN/PI3K通路与血管新生的实验研究[D].成都中医药大学,2010.
[50]葛爱利.参芪复方对糖尿病血管病变患者血清脂联素、瘦素、抵抗素影响的临床研究[D].成都中医药大学,2011.
[51]郑芳.维生素C联合参芪复方治疗糖尿病视网膜病变的临床疗效观察[J].数理医药学杂志,2009,22(3)：294-295.
[2]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志,2012,20(1)：S3.
[3]Stuart C A, Wen G, Williamson M E, et al. Altered GLUT1 and GLUTS gene expression and subcellular redistribution of GLUT4:protein in muscle from patients with acanthosis nigricans and severe insulin resistance[J].Metabolism,2001,50(7):771-777.
[4]Wray C J, Sun X, Gang G I, et al. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle[J]. J Surg Res,2002,104(2):82-87.
[5]项静燕,赵玉武.糖尿病性骨骼肌病变发病机制的研究进展[J].中国老年学杂志,2009(22)：2976-2979.
[6]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠白色脂肪组织脂联素基因表达的影响[J].中成药,2006,28(7)：996-1001.
[7]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3)：249-253.
[8]谢毅强,谢春光,张红敏.参芪复方对GK大鼠2型糖尿病大血管病变CD36 mRNA及ox-LDL的影响[J].时珍国医国药,2007,18(8)：1812-1814.
[9]张红敏,谢春光,陈世伟,等.参芪复方对糖尿病早期大血管病变大鼠白色脂肪过氧化物酶体增生物激活受体γ的影响[J].中医杂志,2007,48(6)：549-551.
[10]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠PI3-K/Akt信号通路的影响[J].中医杂志,2011,52(1)：49-53.
[11]温俊平,林丽香,陈刚,等.2型糖尿病大鼠骨骼肌基因表达谱研究[J].中华内分泌代谢杂志,2006,22(5)：491-492.
[12]张曙云,沈征,钱凯先.2型糖尿病大鼠基因表达变化的研究[J].科技通报,2007,23(3)：368-371.
[13]李翔,刘志民,石勇铨,等.基因芯片技术筛选2型糖尿病伴远端对称性多神经病变患者外周血单个核细胞差异表达基因[J].第二军医大学学报,2006,27(10)：1072-1075.
[14]Haffher S M, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study[J]. Diabetes Care,1996,19(10):1138-1141.
[15]韩为东赵亚力马学斌.分子生物学基本实验技术[M].北京：清华大学出版社,2006.
[16]邓西方.参芪复方改善自发性糖尿病大鼠胰岛素抵抗及抗炎机理研究[D].成都中医药大学,2007.
[17]葛爱利.参芪复方对糖尿病血管病变患者血清脂联素、瘦素、抵抗素影响的临床研究[D].成都中医药大学,2011.
[18]李辉,朱天民,张卫华,等.参芪复方对2型糖尿病GK大鼠胰岛β细胞凋亡及Caspase-3表达的影响[J].中国老年学杂志,2008,28(24)：2412-2413.
[19]刘桠,谢春光,庄灿,等.参芪复方对GK大鼠2型糖尿病大血管病变内皮保护作用的实验研究[J].辽宁中医杂志,2010,37(6)：1163-1165.
[20]张琨,谢春光.参芪复方对GK大鼠2型糖尿病大血管病变氧化应激的影响[J].中华中医药杂志,2012,27(4)：]084-1087.
[21]陈敏,庄灿,谢春光,等.参芪复方对GK大鼠大血管病变内皮细胞凋亡影响的实验研究[J].时珍国医国药,2010,21(9)：2165-2166.
[22]孙凤平,钞建峰,郑君,等.参芪复方对GK大鼠肾PPAR y表达的影响[J].西部中医药,2011,21(11)：12-14.
[23]康健,刘桠,谢春光,等.参芪复方对GK大鼠心肌细胞凋亡相关因Bcl-2、 Bax及NO的影响[J].天津中医药,2009,26(6)：489-492.
[24]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3)：249-252.
[25]李辉,谢春光,朱天民.参芪复方对GK大鼠胰岛β细胞凋亡和诱导型一氧化氮合酶表达的影响[J].时珍国医国药,2008,19(1)：166-167.
[26]谢毅强,谢春光,张红敏.参芪复方对GK大鼠早期动脉硬化胰岛素抵抗的影响[J].海南医学院学报,2007,13(3)：204-207.
[27]王芬,何华亮,张红敏,等.参芪复方对GK大鼠脂代谢异常的实验研究[J].天津中医药,2007,24(6)：507-508.
[28]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠PI3-K/Akt信号通路的影响[J].中医杂志,2011,52(1)：49-52.
[29]张延群,韩清,和贵章,等.2080例糖尿病患者证候与血糖关系分析[J].中医杂志,1996,37(10)：6]7-619.
[30]张延群,韩清,和贵章,等.2080例糖尿病患者证候与血糖关系分析[J].中医杂志,1996,37(10)：617-619.
[31]杨维益,梁嵘,文平,等.脾气虚证大鼠骨骼肌的形态学和形态计量研究[J].中国运动医学杂志,1993(3)：157-159.
[32]Eriksson K F, Saltin B, Lindgarde F. Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance. A 15-year follow-up[J]. Diabetes,1994,43(6):805-808.
[33]蒙碧辉,黄彦云,冼苏,等.21例糖尿病患者骨骼肌毛细血管基底膜厚度分析[J].中华内分泌代谢杂志,1995,11(4)：244.
[34]项静燕,赵玉武.糖尿病性骨骼肌病变发病机制的研究进展[J].中国老年学杂志,2009(22)：2976-2979.
[35]Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature,2001,414(6865):813-820.
[36]Zisman A, Peroni O D, Abel E D, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance[J]. Nat Med,2000,6(8):924-928.
[37]Inoue M, Chang L, Hwang J, et al. The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin[J]. Nature,2003,422(6932):629-633.
[38]刘霞,金其贯,罗强.有氧运动和膳食控制对2型糖尿病大鼠骨骼肌InsR-PI3K-GLUT4信号通路的影响[J].中国运动医学杂志,2012(11)：988-993.
[39]张红学.运动提高糖尿病大鼠骨骼肌GLUT4基因表达的信号机制[J].体育学刊,2013,2(20)：2-6.
[40]Brand M D, Pamplona R, Portero-Otin M, et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3[J]. Biochem J,2002,368(Pt 2):597-603.
[41]Mcgee S L, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression:molecular mechanisms[J]. Clin Exp Pharmacol Physiol,2006,33(4):395-399.
[42]吴慧娟,张志刚.泛素-蛋白酶体途径及意义[J].国际病理科学与临床杂志,2006(1)：7-10.
[43]Takeshita M, Ina K, Kitamura H, et al. Ultrastructural study of capillary and myocytic changes in the masseter and heart of KK-Ay mice[J]. J Electron Microsc (Tokyo),1997,46(5):413-423.
[44]马春明,张宏.糖尿病骨骼肌病变发病机制[J].辽宁实用糖尿病杂志,2004,12(4)：51-53.
[45]Nakahash I T F J I R. V ascu lar endothelial cells syn thesize and secrete brain-derived neu rotroph ic factor[J]. FEBS Lett,2000,2(470):113-117.
[46]Gomez-Pinilla F. Ying Z. Opazo P. et al. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle[J]. Eur J Neurosci.2001.13(6):1078-1084.
[47]Shinoda M, Hoffer B J. Olson L. Interactions of neurotrophic factors GDNF and NT-3, but not BDNF, with the immune system following fetal spinal cord transplantation[J]. Brain Res,1996,722(1-2):153-167.
[48]Durham H A, Truett G E. Development of insulin resistance and hyperphagia in Zucker fatty rats[J]. Am J Physiol Regul Integr Comp Physiol,2006,290(3):R652-R658.
[49]Nakano D, Diah S, Kitada K, et al. Short-Term Calorie Restriction in Early Life Attenuates the Development of Proteinuria but Not Glucose Intolerance in Type 2 Diabetic OLETF Rats[J].1SRN Endocrinol,2011,2011:768637.
[50]尤杰,孙兆林,季宇彬,等.糖尿病动物模型的种类与研究进展[J].中国药业,2012(9)：1-4.
[51]Huang Y, Border W A, Yu L, et al. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathyfj]. J Am SocNephrol,2008,19(2):329-338.
[52]邹丰,欧阳静萍,毛先晴.黄芪多糖对遗传性糖尿病小鼠肝糖原含量的影响[J].微循环学杂志,2007(1)：12-14.
[53]郭清华,陆菊明,潘长玉.饮食能量对KKAy及Kk小鼠2型糖尿病发病的影响[J].军医进修学院学报,2005(2)：140-142.
[54]Kaie Ojamaa S Y H Y. Insulin resistance associated with decreased levels of insulin-receptor mRNA[J]. ournal of clinical endocrinology and metabolism.1998:1214-1220.
[55]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠PI3-K/Akt信号通路的影响[J].中医杂志,2011,52(1)：49-52.
[56]Kataoka C, Egashira K, Ishibashi M, et al. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis[J]. Am J Physiol Heart Circ Physiol,2004,286(2):H768-H774.
[57]Zhao Q, Egashira K, Inoue S, et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis[J]. Circulation,2002,105(9):l 110-1115.
[58]郑瑾,叶平.血管病变早期检测及临床意义[J].心血管康复医学杂志,2012(2)：207-210.
[59]李桂源.病理生理学[M].北京：人民卫生出版社,2010.
[60]沈杰,符鸿俊.罗格列酮对初发2型糖尿病患者血糖、胰岛β细胞功能和炎症因子的影响[J].中国现代医生,2012(32).
[61]邓向群,毕会民.罗格列酮对胰岛素抵抗大鼠骨骼肌蛋白激酶B表达的影响[J].中国新药与临床杂志,2004(5).
[62]胡君平.罗格列酮对2型糖尿病小鼠肌肉萎缩拮抗机制[D].郑州大学,2010.
[63]诸福棠胡亚美江载芳.实用儿科学[M].第7版.北京：人民卫生出版社,2005.
[64]马晖,谢春光.参芪复方降血糖实验研究[J].四川省卫生管理干部学院学报,2006,25(2)：87-89.
[65]Lee J H, Chan J L, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration:cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects[J]. J Clin Endocrinol Metab,2003,88(10):4848-4856.
[66]高泓.参芪复方调控糖尿病血管PB-K/Akt通路的实验研究[D].成都中医药大学,2009.
[67]王芬,何华亮,张红敏,等.参芪复方对GK大鼠脂代谢异常的实验研究[J].天津中医药,2007(6).
[68]姜荷艳,王锐.罗格列酮对2型糖尿病患者血脂及胰岛素抵抗的影响[J].中国误诊学杂志,2007,7(21)：5014-5015.
[69]Stuart C A, Wen G, Williamson M E, et al. Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4:protein in muscle from patients with acanthosis nigricans and severe insulin resistance[J]. Metabolism.2001,50(7):771-777.
[70]Wray C J, Sun X, Gang G I, et al. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle[J]. J Surg Res,2002,104(2):82-87.
[71]张宏,白景文,于德民,等.糖尿病性肌病的超微病理结构及可能机理[J].中国糖尿病杂志,2002,10(6)：326-329.
[72]张晓菲,杨景,张忠辉.罗格列酮对糖尿病大鼠骨骼肌损害防护作用的机制研究[J].中国医药指南,2012(24).
[73]Wang Z, Du Q, Wang F, et al. Microarray analysis of gene expression on herbal glycoside recipes improving deficient ability of spatial learning memory in ischemic mice[J]. J Neurochem,2004,88(6):1406-1415.
[74]周红光,陈海彬,王瑞平,等.代谢组学在中药复方研究中的应用[J].中国药理学通报,2013,29(2)：161-165.
[75]陈芝喜,徐志伟,刘小斌,等.脾虚证小鼠脾肾组织核酸和蛋白质含量变化及强肌健力口服液的影响(英文)[J].中国组织工程研究与临床康复,2007,11(8)：1581-1584.
[76]Cao P R, Kim H J, Lecker S H. Ubiquitin-protein ligases in muscle wasting[J]. Int J Biochem Cell Biol,2005,37(10):2088-2097.
[77]Yanagawa Y, Komatsu S. Ubiquitin/proteasome-mediated proteolysis is involved in the response to flooding stress in soybean roots, independent of oxygen Iimitation[J]. Plant Sci,2012,185-186:250-258.
[78]Larsen C N, Finley D. Protein translocation channels in the proteasome and other proteases[J]. Cell,1997,91 (4):431-434.
[79]Wu C, Zhang Y, Sun Z, et al. Molecular evolution of Cide family proteins:novel domain formation in early vertebrates and the subsequent divergence[J]. BMC Evol Biol,2008,8:159.
[80]Dupont-Versteegden E E. Apoptosis in skeletal muscle and its relevance to atrophy[J]. World J Gastroenterol,2006,12(46):7463-7466.
[81]Joza N, Pospisilik J A, Hangen E, et al. AIF:not just an apoptosis-inducing factor[J]. Ann N Y Acad Sci,2009,1171:2-11.
[82]Jin R, De Smaele E, Zazzeroni F, et al. Regulation of the gadd45beta promoter by NF-kappaB[J]. DNA Cell Biol,2002,21(7):491-503.
[83]Papa S, Zazzeroni F, Bubici C, et al. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2[J]. Nat Cell Biol,2004,6(2):146-153.
[84]Papa S, Zazzeroni F, Bubici C, et al. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2[J]. Nat Cell Biol,2004,6(2):146-153.
[85]Lang F, Henke G, Embark H M, et al. Regulation of channels by the serum and glucocorticoid-inducible kinase-implications for transport, excitability and cell proliferation[J]. Cell Physiol Biochem,2003,13(1):41-50.
[86]Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition[J]. Expert Opin Investig Drugs,2013.
[87]Pati D, Zhang N, Plon S E. Linking sister chromatid cohesion and apoptosis:role of Rad21[J]. Mol Cell Biol,2002,22(23):8267-8277.
[88]Meirelles G V, Silva J C, Mendonca Y A, et al. Human Nek6 is a monomeric mostly globular kinase with an unfolded short N-terminal domain[J]. BMC Struct Biol,2011,11(12):576-582.
[89]Dosztanyi Z, Csizmok V, Tompa P, et al. IUPred:web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content[J]. Bioinformatics,2005,21(16):3433-3434.
[90]Cheng J, Randall A Z, Sweredoski M J, et al. SCRATCH:a protein structure and structural feature prediction server[J]. Nucleic Acids Res,2005,33(Web Server issue):W72-W76.
[91]王萍.高学文.李润今.等.星形胶质细胞和神经元凋亡的细胞周期时相分布特征[J].中华神经医学杂志.2008.7(4)：329-332.
[92]唐振宇.大鼠脊髓损伤后NEK6表达的实验研究[J].淮海医药.2011.29(6)：473-475.
[93]Sasaki S, Nakamura T, Arakawa H, et al. Isolation and characterization of a novel gene, hRFI. preferentially expressed in esophageal cancer[J]. Oncogene,2002,21(32):5024-5030.
[94]张玉秀,柴团耀,赵文明.遍在蛋白系统[J].生命的化学,1999(5)：34-36.
[95]陈洪菊,屈艺,母得志.nTOR言号通路的生物学功能[J].生命的化学.2010,30(4)：555-561.
[96]马振莲,刘少君.轴突导向信号的研究进展[J].军事医学科学院院刊,2006,30(2)：180-183.
[97]Hadjantonakis A K, Sheward W J, Harmar A J, et al. Celsr1, a neural-specific gene encoding an unusual seven-pass transmembrane receptor, maps to mouse chromosome 15 and human chromosome 22qter[J]. Genomics,1997,45(1):97-104.
[98]Rocak S, Linder P. DEAD-box proteins:the driving forces behind RNA metabolism[J]. Nat Rev Mol Cell Biol,2004,5(3):232-241.
[99]Peelman L J, Chardon P, Nunes M, et al. The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family[J]. Genomics,1995,26(2):210-218.
[100]Sahni A, Wang N, Alexis J D. UAP56 is an important regulator of protein synthesis and growth in cardiomyocytes[J]. Biochem Biophys Res Commun,2010,393(1):106-110.
[101]Sahni A, Wang N, Alexis J D. UAP56 is a novel interacting partner of Bcr in regulating-vascular smooth muscle cell DNA synthesis[J]. Biochem Biophys Res Commun,2012,420(3):511-515.
[102]Deshaies R J, Joazeiro C A. RING domain E3 ubiquitin ligases[J]. Annu Rev Biochem,2009,78:399-434.
[103]Peters J M. Subunits and substrates of the anaphase-promoting complex[J]. Exp Cell Res,1999,248(2):339-349.
[104]Vogel G. Nobel Prizes. Gold medal from cellular trash[J]. Science,2004,306(5695):400-401.
[105]van Roessel P, Elliott D A, Robinson I M, et al. Independent regulation of synaptic size and activity by the anaphase-promoting complex[J]. Cell,2004,119(5):707-718.
[106]Weedon M N, Lango H, Lindgren C M, et al. Genome-wide association analysis identifies 20 loci that influence adult height[J]. Nat Genet,2008,40(5):575-583.
[1]马晖,谢春光.参芪复方降血糖实验研究[J].四川省卫生管理干部学院学报.2006,25(2)：87-89.
[2]王芬,何华亮,张红敏,等.参芪复方对GK大鼠脂代谢异常的实验研究[J].天津中医药,2007,24(6)：507-508.
[3]谢毅强,谢春光,张红敏.参芪复方对GK大鼠早期动脉硬化胰岛素抵抗的影响[J].海南医学院学报,2007,13(3)：204-207.
[4]邓西方.参芪复方改善自发性糖尿病大鼠胰岛素抵抗及抗炎机理研究[D].成都中医药大学,2007.
[5]李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4)：5-7.
[6]Freeman D J, Norrie J, Caslake M J, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study [J]. Diabetes,2002,51(5):1596-1600.
[7]Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue[J]. Circulation,2003,107(5):671-674.
[8]张红敏,陈世伟,谢春光,等.参芪复方抗自发性糖尿病GK大鼠早期动脉粥样硬化的作用机制[J].中国中药杂志,2006,31(15)：1272-1275.
[9]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3)：249-252.
[10]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠白色脂肪组织脂联素基因表达的影响[J].中成药,2006,27(7)：996-1000.
[11]禹远远,王瑞英,郝咏梅.血管内皮功能紊乱与糖尿病大血管病变[J].临床荟萃,2008,23(20)：1515-1517.
[12]段薇,张锦,张学梅,等.内皮抑素和血管内皮生长因子与2型糖尿病大血管病变的关系[J].中国动脉硬化杂志,2006,14(9)：799-801.
[13]巩秋红,刘晓民,于友涛.血清一氧化氮水平与2型糖尿病血管病变的关系[J].中国糖尿病杂志,2000,8(2)：103.
[14]Dhaliwal B S, Steinbrecher U P. Scavenger receptors and oxidized low density lipoproteins[J]. Clin Chim Acta,1999,286(1-2):191-205.
[15]Nakata A, Nakagawa Y, Nishida M, et al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta[J]. Arterioscler Thromb Vase Biol,1999,19(5):1333-1339.
[16]刘桠,谢春光,庄灿,等.参芪复方对GK大鼠2型糖尿病大血管病变内皮保护作用的实验研究[J].辽宁中医杂志,2010,37(6)：1163-1165.
[17]谢毅强,谢春光,张红敏.参芪复方对自发性糖尿病大鼠血管内皮保护的作用机制[J].中华中医药杂志,2008,23(3)：253-255.
[18]谢毅强.参芪复方对GK大鼠2型糖尿病大血管病变血管内皮细胞保护的实验研究[J].2006.
[19]金惠铭,李先涛.血管新生的调控[J].中国微循环,2001,5(2)：85-88.
[20]Moreno P R, Purushothaman K R, Zias E, et al. Neovascularization in human atherosclerosis[J]. Curr Mol Med,2006,6(5):457-477.
[21]Dai J, Rabie A B. VEGF:an essential mediator of both angiogenesis and endochondral ossification[J]. J Dent Res,2007,86(10):937-950.
[22]Adya R, Tan B K, Punn A, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis[J]. Cardiovasc Res,2008,78(2):356-365.
[23]刘桠.参芪复方调控GK大鼠血管PTEN/PI3K通路与血管新生的实验研究[J].2011.
[24]高泓.参芪复方调控糖尿病血管PI3-K/Akt通路的实验研究[J].2010.
[25]高泓,谢春光,刘桠,等.参芪复方对糖尿病大血管病变GK大鼠P13-K/Akt言号通路的影响[J].中医杂志,2011,52(1)：49-52.
[26]Nathan C, Xie Q W. Regulation of biosynthesis of nitric oxide[J]. J Biol Chem,1994,269(19):13725-13728.
[27]Fehsel K, Kroncke K D, Meyer K L, et al. Nitric oxide induces apoptosis in mouse thymocytes[J]. J Immunol,1995,155(6):2858-2865.
[28]Geng Y J, Hellstrand K, Wennmalm A, et al. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha[J]. Cancer Res,1996,56(4):866-874.
[29]李辉,朱天民,张卫华,等.参芪复方对2型糖尿病GK大鼠胰岛β细胞凋亡及Caspase-3表达的影响[J].中国老年学杂志,2008,28(24)：2412-2413.
[30]李辉,谢春光,朱天民.参芪复方对GK大鼠胰岛β细胞凋亡和诱导型一氧化氮合酶表达的影响[J].时珍国医国药,2008,19(1)：166-167.
[31]陈敏,庄灿,谢春光,等.参芪复方对GK大鼠大血管病变内皮细胞凋亡影响的实验研究[J].时珍国医国药,2010,21(9)：2165-2166.
[32]Talior I, Tennenbaum T, Kuroki T, et al. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice:role for NADPH oxidase[J]. Am J Physiol Endocrinol Metab,2005,288(2):405-411.
[33]张琨,谢春光.参芪复方对GK大鼠2型糖尿病大血管病变氧化应激的影响[J].中华中医药杂志,2012,27(4)：1084-1087.
[34]宋新磊,王静,崔焕先,等PPARy对脂类代谢和脂肪细胞分化的调控[J].云南农业大学学报,2008,23(6)：851-855.
[35]Nencioni A, Wesselborg S, Brossart P. Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses[J]. Crit Rev Immunol,2003,23(1-2):1-13.
[36]Soller M, Tautenhahn A, Brune B, et al. Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis[J]. J Leukoc Biol,2006,79(1):235-243.
[37]Artwohl M, Holzenbein T, Furnsinn C, et al. Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells[J]. Thromb Haemost,2005,93(5):810-815.
[38]Barzilay J I, Abraham L, Heckbert S R, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J]. Diabetes,2001,50(10):2384-2389.
[39]孙凤平,钞建峰,郑君,等.参芪复方对GK大鼠肾PPARγ表达的影响[J].西部中医药,2011,21(11)：12-14.
[40]曾娜.参芪复方对自发性糖尿病肾病大鼠血清CRP、TNF-α和E-selectin水平表达影响的研究[J].2011.
[41]张芳林.糖尿病性心肌病发病机理的研究进展[J].国外医学.内分泌学分册,2002,7(4)：245-247.
[42]温晨东,李兴.细胞因子与糖尿病心肌病变[J].医学综述,2006,12(1)：34-36.
[43]Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue[J]. Circulation,2003,107(5):671-674.
[44]Bojestig M, Nystrom F H, Amqvist H J, et al. The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes[J]. J Renin Angiotensin Aldosterone Syst,2000,1(4):353-356.
[45]Cai L, Li W, Wang G, et al. Hyperglycemia-induced apoptosis in mouse myocardium:mitochondrial cytochrome C-mediated caspase-3 activation pathway[J]. Diabetes,2002,51(6):1938-1948.
[46]De Falco M, Laforgia V, Fedele V, et al. Vasoactive intestinal peptide stimulation modulates the expression of Bcl-2 family members in the adrenal gland of the lizard Podarcis sicula[J]. Histochem J,2001,33(11-12):639-645.
[47]康健.刘桠.谢春光,等.参芪复方对GK大鼠心肌细胞凋亡相关因子Bcl-2、Bax及NO的影响[J].天津中医药.2009,26(6)：489-492.
[48]殷丽平,谢春光,张红敏,等.参芪复方对自发性糖尿病GK大鼠心肌LTGF-β1表达的影响[J].福建中医药,2009,40(3)：38-40.
[49]刘桠.参芪复方调控GK大鼠血管PTEN/PI3K通路与血管新生的实验研究[D].成都中医药大学,2010.
[50]葛爱利.参芪复方对糖尿病血管病变患者血清脂联素、瘦素、抵抗素影响的临床研究[D].成都中医药大学,2011.
[51]郑芳.维生素C联合参芪复方治疗糖尿病视网膜病变的临床疗效观察[J].数理医药学杂志,2009,22(3)：294-295.